Liu Hui
Fortune : 207 157 $ au 30/09/2026
Fortune : 207 157 $ au 30/09/2026
Dr. Liu Hui is an Independent Director at Rallybio Corp.
He is on the Board of Directors at Rallybio Corp.
Dr. Hui was previously employed as a Chief Business Officer & Executive Vice President by Merus NV and a VP & Head-Business Development & Licensing by Novartis AG.
He received his undergraduate degree from Peking University, an MBA from the University of Michigan and a doctorate degree from the University of Michigan.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RALLYBIO CORPORATION 0,23 % | 24/09/2026 | 12 044 ( 0,23 % ) | 207 157 $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| RALLYBIO CORPORATION | Directeur/Membre du Conseil | 04/04/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| MERUS N.V. | Corporate Officer/Principal | 01/07/2024 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national